NPC1L1 and neuroblastoma: Additionally, we observed that neuroblastoma cells exhibited synergistic sensitivity to FLIX5 when combined with ezetimibe, which targets NPC1L1 and blocks intestinal cholesterol absorption (Fig. 4D, E).